A great majority of patients seeking preimplantation genetic diagnosis (PGD) are women >35 years of age. In addition to being carriers for single gene defects, these women also have a higher risk of having children with Down's syndrome (trisomy 21). For these patients, it would be advantageous if a diagnostic test for trisomy 21 was developed, which could be used in conjunction with tests for single gene defects. Here, we assessed the feasibility of developing an accurate genetic test for diagnosing trisomy 21 and the mutation causing spinal muscular atrophy (SMA) in single cells using multiplex fluorescence polymerase chain reaction (PCR). Single-and two-round PCR were developed using a combination of primers for the survival motor neuron (SMN) gene exons 7 and 8 and two chromosome 21 short tandem repeats (STRs), D21S226 and D21S11. After only 36 cycles, 88 and 68% of normal single cells were screened for SMA mutations and trisomy 21 respectively. In multiplex PCR using only two primers (SMN exon 7 and D21S11) instead of four, the efficiency of SMA diagnosis was increased to 93%. In the same reactions, the D21S11 alleles were detected in 83% of the normal single cells. Clinical applications of this assay should enable detection of those embryos that have inherited three heterozygous alleles and, therefore, benefit many PGD patients who are at an increased risk of Down's syndrome.
Introduction
error. For this reason, precautions must be taken in its use for clinical diagnosis. One of the potential problems for PGD is In the 10 years since the first preimplantation genetic diagnosis the amplification of only one of the two parental alleles from (PGD) clinical trial, PGD has been performed for many heterozygous cells, called allelic drop-out (ADO). ADO is common chromosomal abnormalities and inherited single gene observed only after PCR amplification from single or small defects. To date,~1200 PGD cycles (polar body and blastomere numbers of cells and affects both alleles randomly (Findlay biopsies) have been reported and 166 healthy children have et al., 1995a) . In reports that have examined ADO, the been born . As more couples frequency of amplification failure has varied. Different groups become aware of PGD as a viable alternative to other forms have quoted ADO frequencies ranging from 0.8-36% for of prenatal testing (i.e. amniocentesis and chorionic villus cystic fibrosis genetic analysis (Strom et al., 1990 (Strom et al., , 1994 Wu sampling) , PGD laboratories will need to develop a wider et al., 1993; Avner et al., 1994; Ray et al., 1994 Ray et al., , 1996 ; Gitlin range of accurate diagnostic tests for single cell analysis.
et . Although the exact cause The first PGD cases involved embryo sexing to avoid of ADO is not known, it is believed that it may be due to X-linked diseases (Handyside et al., 1990) . Diagnosis was suboptimal PCR conditions (Wu et al., 1993; Sermon et al. , performed using PCR protocols designed to amplify Y-specific 1995; Gitlin et al., 1996; Kontogianni et al., 1996; , repeat sequences from biopsied blastomere cells. Although 1996) or degradation of target DNA molecules (Findlay et al. , conventional PCR has proven to be a very sensitive technique, 1995a; Ray and Handyside, 1996) . Another potential difficulty amplification of X and Y sequences does not provide informais chromosomal mosaicism. This is observed as two or more tion about chromosome copy number. With the development cells from the same embryo having different chromosome of multicolour fluorescent in-situ hybridization (FISH), it complements. Recently, FISH studies have shown that a is now possible to detect autosomes, as well as both sex significant number of normally developing embryos display chromosomes (Griffin et al., 1994; Munné et al., 1994) . chromosome mosaicism (Munné et al., 1993; Harper et al., Currently, FISH is the preferred method for PGD embryo 1995; Delhanty et al., 1997) . For genetic analysis, ADO and sexing and aneuploidy screening for women of advanced chromosomal mosaicism will not cause serious misdiagnosis maternal age (Gianaroli et al., 1997; Smith et al., 1998) .
in an autosomal recessive disorder (involving one mutation) Though not used widely for sex selection, PCR is the only because at least one of the two mutated alleles will be detected method that is sensitive enough to detect single gene mutations.
within an affected homozygous embryo. However, in autosomal dominant conditions, or in autosomal recessive compound Owing to its sensitivity, PCR is highly prone to sources of heterozygotes, failure to amplify the mutant allele (PCR failure yet, these PCR assays have only been used to confirm karyotype diagnosis. or loss of the chromosome) will lead to transfer of an affected embryo (Navidi and Arnheim, 1991) . A significant number of PGD patients are women who have already experienced the birth of one affected child or have Advances in single cell genetic analysis have prompted different groups to address the problem of ADO and chromohad several terminated pregnancies after prenatal testing. Often by the time these women enrol in a PGD programme they are somal mosaicism. Recent work in the detection of a dominant mutation in the familial adenomatous polyposis coli gene approaching 35 years of age. At this stage, in addition to being carriers for a single gene defect, they have a greater chance (Groden et al., 1991) has led to the development of a strategy to detect ADO in clinical PGD cases (Ao et al., 1998) . The of having a trisomy pregnancy (Hook et al., 1983) . For many PGD couples, it would be beneficial if an assay was developed approach involves whole genome amplification from a single cell by primer extension pre-amplification (PEP) (Zhang et al., that allowed a test for trisomy 21 to be used in conjunction with their test for a single gene defect. To develop such a 1992), followed by nested PCR. Here, multiple loci can be analysed. By incorporating a linked polymorphism in the PCR strategy, we chose to analyse the single gene defect associated with spinal muscular atrophy (SMA). SMA is an autosomal assay, it is possible to decrease the risk of misdiagnosis due to ADO and the inadvertent sampling of a haploid cell. The recessive disorder, resulting in the degeneration of motor neurons of the spinal cord. The condition causes progressive PCR co-amplification of a linked polymorphic marker has also been used in the development of diagnostic tests for β-limb and trunk paralysis accompanied by muscular atrophy.
With a calculated incidence of 1/6000-1/10 000 live births thalassaemia and cystic fibrosis . (Dubowitz, 1995) and a carrier frequency between 1/40-1/60 (Pearn, 1980; Melki et al., 1994) , SMA is the second most Fluorescent-based DNA detection technology, first developed for automated sequencing (Ansorge et al., 1986) , has common childhood genetic disorder after cystic fibrosis (Pearn et al., 1973) . been adapted for PCR fragment analysis and applied for genetic screening (Schwartz et al., 1992; Lewis et al., 1993;  Recently, PGD has been performed for SMA by using conventional PCR and ethidium bromide staining (Dreesen Mansfield et al., 1993; Toth et al., 1997 Toth et al., ,1998 Findlay et al., 1998a; Sermon et al., 1998a,b) . Incorporation of fluorescentlyet al., 1998) . Our aim was to develop an accurate fluorescencebased PCR assay for both trisomy 21 and SMA that could be labelled primers into PCR products enable a laser excitation/ detection system to register the DNA fragments as excitation used for future clinical PGD. In this paper, we discuss the benefits, as well as the limitations, of developing multiplex peaks; a system more sensitive than standard gel electrophoresis (Hattori et al., 1992) . The signal intensities of the fluorescent PCR for single cell analysis. peaks can be compared and applied for quantitative PCR analysis. As a consequence of the increased sensitivity with fluorescent-PCR, a low ADO rate (~4%) has been reported Materials and methods (Findlay et al, 1995a) due to an ability to distinguish true ADO Cell culture from preferential amplification of one allele over the other.
An SMA-affected lymphocyte cell line was provided by Dr Louise It has been reported that 3% of newborn children have a Simard (Hôpital Sainte-Justine, Montreal, Canada) . Cells were mainclinically recognized birth defect (Kalter and Warkany, 1983) . tained in culture using RPMI culture media (Gibco-BRL, Burlington, The majority of these cases are caused by a chromosomal Ontario, Canada) supplemented with 10% fetal calf serum (Gibcoimbalance. Of these disorders, trisomy 21 (Down's syndrome) BRL).
is one of the most common, occurring in one in every 600
Genomic DNA was isolated from cultures of trisomy 21 affected births (Hook, 1992) . For women aged Ͼ35 years there is an amniocytes (Dr. Alessandra Duncan, Montreal Children's Hospital, increased risk of having a trisomy 21 pregnancy (Hassold Montreal, Quebec, Canada) by organic extraction (Sambrook et al., 1989 (Sambrook et al., ). et al., 1996 . Both maternal meiosis I and II errors have been associated with advanced maternal age (Antonarakis et al., 1992; Mikkelsen et al., 1995; Yoon et al., 1996) . However, Yoon et al., 1996) . , 1996) and amniotic fluid obtained from normal individuals using PBS. Cell samples were then et al., 1998b) samples, using short tandem repeat sequences washed in the same manner as described above for lymphocytes.
(STRs). These tests are rapid, offering same day diagnosis, However, single cells were lysed after a 1 h incubation at 37°C, using and have been shown to be highly accurate when applied to proteinase K and sodium dodecyl sulphate buffer (Holding et al., 1993), followed by inactivation of the enzyme at 95°C for 15 min.
single cell analysis (Findlay et al., 1998b) . However, as of
Blastomeres Detection of SMN telomeric copy
To distinguish between the two copies of SMN, PCR products were The source of blastomere cells were from 'spare' embryos donated for research by patients undergoing routine in-vitro fertilization (IVF) digested with either HinfI (exon 7) or DdeI (exon 8) restriction enzymes (Gibco-BRL). PCR aliquots of 5 µl were added to 1ϫ enzyme treatment at the McGill Reproductive Center, Royal Victoria Hospital, Montreal, Canada. The centre's policy is to transfer or freeze buffer, 10 IU of enzyme in a total volume of 10 µl and incubated at 37°C for 2 h. all high-grade embryos; the grade (1-4) assigned was based on morphological criteria. 'Spare' embryos donated to research generally Analysis of PCR products are of poorer quality than those kept for future embryo transfer. Therefore, research embryos used in this study were grade 3 or 4.
The fluorescently labelled amplified DNA was visualized by running Cleavage stage embryos were disaggregated with acid Tyrode's products on an ALFexpress sequence analyser (Amersham Pharmacia solution (Sigma, Oakville, Ontario, Canada) and the individual Biotech). PCR products were mixed with 5 µl of loading dye and blastomere cells washed in drops of PBS. Cellular fragments were denatured for 3 min at 90°C prior to the samples being loaded ignored and only those cells with a visible nucleus were collected in onto a 9% bis/acrylamide denaturing gel. DNA was visualized as 5 µl of alkaline lysis buffer and used for genetic analysis.
fluorescent peaks using the instruments packaged computer software. A fluorescently labelled 50-500 bp marker (Amersham Pharmacia PCR conditions Biotech) was loaded onto each gel and used to size peak fragments. To screen for SMA mutations we used primer sequences for exon 7 (outer forward: 5-TGCAGCCTAATAATTGTTTTCTTTG-3; inner , 1995) . DNA primers were designed to amplify D21S226 500 kb inverted repeat (Lefebvre et al., 1995) . The candidate that this affected fetus inherited three different sized alleles for this locus (Figure 3d) . Conversely, analysis of D21S11 from the same affected sample shows a diallelic pattern, where fragment ratio produced from PCR amplification of normal cells. As illustrated in Figure 3a ,b, amplification of both one allele has a peak intensity 2ϫ the value of the second allele (Figure 3c ). By using a second STR to assay the same D21S226 and D21S11 from normal single cells produce the expected two allele profile. However, in 100 pg of DNA sample, it has been possible to confirm the trisomy 21 genotype for this affected fetus. extracted from amniotic fluid samples, the STRs display a Survival motor neuron (SMN) gene exon 7 centromeric (C) and telomeric (T) copies can be resolved because of a HinfI restriction site present only in the amplified telomeric copy. By analysing the different alleles (*) for the two short tandem repeats (STRs), this sample was shown to be heterozygous for D21S226 and homozygous for D21S11.
Dual testing for SMA and trisomy 21: single round (Handyside et al., 1990) and cystic fibrosis analysis round fluorescent PCR for the screening of SMA and trisomy 21 in single cells. First, the amplification rates of the individual primer sets were examined, using only 36 PCR cycles. Under produced in only 46% of these cells, 88% of the cells could these conditions, both SMN exons 7 and 8, and D21S11 be screened for SMA and 68% for trisomy 21. produced high amplification rates (ജ93%), whereas D21S226
In order to be used clinically for PGD, diagnostic tests must was slightly lower (86%) ( Table I ). The high rates calculated have high amplification and accuracy rates. The results of the for each primer set are in agreement with earlier results which multiplex PCR experiments demonstrate that combining all demonstrated the sensitivity of single round fluorescence PCR four-primer sets compromises SMA and trisomy 21 screening. for single cell analysis (Findlay et al., 1995a) .
However, the amplification rate can be increased significantly When all four primer sets are used in single cell multiplex in normal cells when only SMN exon 7 (93%) and D21S11 reactions, the expected profile is produced (Figure 4) . Although (75%) primers are used in multiplex reactions for a single both STRs are detected in this multiplex PCR, the relatively round of 40 cycles (Table I) . small peak sizes are likely due to the presence of 'stutter Dual testing for SMA and trisomy 21: two round bands'. In addition, amplified exon 8 proved to be too small multiplex fluorescent PCR to be adequately digested with DdeI restriction enzyme. Nevertheless, digesting SMN PCR products with HinfI allows Although single round multiplex PCR (exon 7 and D21S11 the amplified exon 7 SMNt fragment to be resolved from co-amplification) showed high primer amplification rates for SMNc, producing the three fragments (the 24 bp fragment SMA diagnosis, we found the amount of amplified exon 7 from exon 7 co-migrates with unincorporated primers) typical varied between samples. In a percentage of normal cells (14%), of normal and carrier cells. However, combining the four the digested exon 7 fragments were nearly too small to be primer sets in a single PCR reaction lowered the amplification detected by fluorescent PCR. rates. Out of 60 normal buccal cells, 52 cells (87%) amplified
As an alternative to this test, we developed a two round exon 7, whereas individually exon 8, D21S226 and D21S11 fluorescent PCR assay to screen for SMA and trisomy 21, as were detected in 38 (63%), 31 (52%) and 40 (67%) of tested well as contamination. In this case, we optimized conditions that enabled simultaneous amplification of SMN exon 7 and samples respectively. Although a complete DNA profile was 
ADO ϭ allelic drop-out; N ϭ normal allele; ∆ ϭ deleted allele.
profile). Conversely, the amplification rate for D21S11 was 86% (36 out of 42). By excluding the possibility of chromosomal mosaicism, the STR profiles of a single blastomere cell should be representative of all the cells collected from the same embryo. Using this criterion, we calculated the ADO rate by examining the different STR profiles produced from a single embryo. From the analysis of 13 embryos, the calculated ADO rate for D21S11 in this PCR assay was 14% (five out of 36). In these experiments, two different cell lysis buffer systems were used; proteinase K for single round and alkaline lysis buffer for nested PCR. No significance in PCR amplification efficiencies have been found between cells in proteinase K versus alkaline lysis buffer (data not shown).
Discussion
For a couple seeking PGD for a specific single gene defect, e.g. cystic fibrosis, the risk of having an affected embryo is 25% (autosomal recessive condition). On the other hand, it is 50% for couples carrying a mutation for a dominant disorder (e.g. myotonic dystrophy). Often, it is only after the birth of IVF studies have shown that fertility rates decline with advanced maternal age (Tan et al., 1992) . The changes in these D21S11. The data from the diagnosis of single normal and SMA-affected lymphocytes is shown in Table II . From the rates have been linked with an increase in the incidence of chromosomal abnormalities. It has been reported that 50% analysis of 161 total single lymphocyte cells, the test for SMA was shown to have high amplification (93%, 150 out of 161 of all spontaneous abortions are chromosomally abnormal (Hassold, 1986) . However, this rate is much higher for older amplified) and accuracy (100%, 150 out of 150 showed the correct diagnosis) rates. For screening of trisomy 21, STR women (Eiben et al., 1990) . In this case, the difference is largely due to a significant rise in the number of trisomies. In profiles were detected in 134 (83%) of the 161 cells tested. The calculated ADO rate in this assay was 10%. There was one clinical trial, the estimated rate of trisomy for women aged ജ40 years was~30% (Hassold and Chiu, 1985) . Therefore, in co-amplification of exon 7 and D21S11 in 128 cells (79%). Representative results of two samples screened for SMA and addition to being carriers for a single gene defect, older PGD couples are also at an increased risk of having a chromosomally trisomy 21 are shown in Figure 5 .
Prior to clinical application, the amplification and accuracy abnormal fetus. In the past, PGD has only been used to diagnose a single genetic disorder. However, more recently, rates of this assay were assessed in normal single blastomeres. Two rounds of PCR amplification were performed on a total efforts have been made to develop tests that can be used to screen for single gene disorders and chromosomal abnormalitof 42 blastomere cells. The amplification rate for exon 7 was 81% (34 out of 42) and the accuracy of SMA diagnosis 100%
ies (Findlay et al., 1995b; Rechitsky et al., 1996) . Fluorescent PCR has been shown to be a rapid and accurate (i.e. 34 out of 34 samples produced the expected fragment technique to screen single cells for genetic mutations. Com-36 cycles. In SMA patients, Ͼ90% of individuals lack both SMNt exons 7 and 8. Therefore, initially, we used primer sets pared with conventional PCR methods, fluorescent PCR has many distinct advantages for clinical PGD. Firstly, genetic for these two exons to screen for SMA mutations. Similarly, two STRs (D21S226 and D21S11) were used to assess the analysis can be performed after a single round of amplification with as few as 36 PCR cycles (Findlay et al., 1995a) . This accuracy of trisomy 21 screening, as well as being controls for contamination. Although co-amplification of both SMN not only reduces the time required to make the diagnosis but with fewer PCR cycles there is less chance of non-specific exons 7 and 8 was 91% in single buccal cells (Table I) , combining all four primers in one reaction lowered the ampliamplification of contaminating DNA. Secondly, fluorescentbased systems are highly amenable to multiplex PCR. While fication rate for each set. With the largest differences seen in the rates calculated for D21S226 and SMN exon 8 (34 and multiplex PCR can be achieved and the products visualized by conventional PCR methods (Chamberlain et al., 1988) , 30% drop in amplification rates for D21S226 and exon 8 primers respectively). Nevertheless, by analysing SMN exons small base pair differences cannot be resolved. However, fluorescent based systems are highly accurate, allowing frag-7 or 8 and either of the two STRs, 88% of cells could be tested for SMA mutations and 68% for trisomy 21. ments differing by 1-2 bp to be distinguished by gel electrophoresis. Furthermore, packaged computer software allows These results agree with previous studies describing the amplification rates of fluorescent multiplex PCR in single cells easy quantification of fluorescently-labelled PCR products, which has great potential for PCR based aneuploidy screening. (Sherlock et al., 1998; Findlay et al., 1999) . In one study, embryo sexing of single blastomeres, using amelogenin Already, fluorescent PCR has been developed at the single cell level for DNA fingerprinting (Findlay et al., 1995b (Findlay et al., , 1997 ; primers, was shown to have an amplification rate of 95% and an accuracy rate of 99%. However, when the same amelogenin single gene disorders (Findlay et al., 1995a; Sermon et al., 1998a Sermon et al., ,b, 1999 Sherlock et al., 1998) , sexing (Findlay et al., primers are used in combination with five (multiple trisomy) or six other primer sets (DNA fingerprinting), the amplification 1995a, 1998a; Sherlock et al., 1998) and aneuploidy screening (Findlay et al., 1998a; Sherlock et al., 1998) . Additionally, to rate for sexing cells dropped to 68 and 84% respectively (Findlay et al., 1999) . From our own experience, we found date, this system has been applied for clinical PGD of myotonic dystrophy (Sermon et al., 1998b ), Marfan's syndrome (Sermon that PCR conditions had to be re-standardized with the incorporation of each additional primer set. By using only two et al., 1999), Huntington's disease (Sermon et al., 1998a) and embryo sexing (Findlay et al., 1999) .
primers (SMN exon 7 and D21S11) instead of four, the primer amplification rates could be increased for both SMA (93%) In developing a test for myotonic dystrophy, Sermon et al. (1998b) were able to demonstrate a reduction in ADO rates and trisomy 21 (75%) screening. We developed single round fluorescent multiplex PCR for as a consequence of using fluorescent PCR. In lymphocytes the ADO rate was Ͼ20% by conventional PCR (Sermon single cell analysis, however, we found that either: (i) the amplification rates were not high enough for clinical PGD, or et al., 1997 PGD, or et al., , 1998b . This value decreased to only 6.5% in lymphocytes using fluorescent PCR analysis (Sermon et al., (ii) in a percentage of cells (14%) the amount of exon 7 produced was too small to be digested. As an alternative, a 1998b). As in conventional PCR, a range of ADO rates have been reported using fluorescent PCR (Findlay et al., 1995b, two round PCR assay was developed. In normal and SMAaffected lymphocytes, the test for SMA was shown to have a 1999), thus emphasizing the importance of careful PCR standardization. To lower the risk of serious misdiagnosis due to 93% amplification rate and 100% accuracy rate, whereas the amplification rate of D21S11 was 83%. By using a second ADO, one method is to use several primer sets within the same reaction (i.e. multiplex PCR). For example, multiplex round of PCR, we have increased the amplification rate of D21S11 (up 8% as compared with single round PCR). However, PCR has been developed at the single cell level using polymorphic STR. For the analysis of common chromosomal in the different PCR assays amplification rates for D21S11 were consistently lower than those calculated for exon 7. In abnormalities, the multiplexing of two chromosome 21 STRs (D21S11 and D21S167) was shown to have a 100% amplificamany reactions, small peaks, usually a repeat length apart, could be seen migrating with each major STR allele. These tion rate, for either of the two markers (only 74% amplification rate for both), and a 100% accurate rate in all known trisomy additional peaks are likely to be stutter bands. If within a reaction these stutter fragments are preferentially amplified, it cells (Findlay et al., 1998b) .
The high degrees of heterozygosity produced by many STRs may affect the amplification rate of the larger STR allele. In comparison, the amplification rates in normal single make these markers highly suitable for DNA fingerprinting. One obvious application is for forensic analysis (Micka et al., blastomere cells were 81% for exon 7 and 86% for D21S11. In this study, only grade 3 and 4 embryos were analysed, 1996). However, DNA fingerprinting can also be beneficial for PGD. If, prior to PGD, parental STR profiles are analysed, which may account for low amplification rates for these experiments. It is commonly observed that embryos with samples with contaminating DNA can be easily identified and discarded.
poor morphology (i.e. excessive fragmentation) give lower amplification rates than those embryos which appear developIn the development of a diagnostic test for SMA and trisomy 21 in single cells, we exploited many of the methods described mentally normal (Ao et al., 1996) . Unlike multiplex reactions developed for single round ampliabove. To avoid misdiagnosis due to ADO or contamination, we first developed a multiplex fluorescent PCR assay for SMA fication of single cells, this two round PCR assay is not quantitative. As a consequence, it is not possible to diagnose and trisomy 21 in single cells, using a single PCR round of diallelic trisomy samples (i.e. double dose). Nonetheless, by primers for SMN and D21S11. The use of a STR marker, like D21S11, is not an appropriate internal control for quantitative including the STR within the assay, it will be possible to diagnose trisomy 21 in the proportion of affected cells dis-PCR because of the propensity of these repeats to form stutter bands. However, we have shown the feasibility of amplifying playing a triallelic pattern, due to meiosis I non-disjunction. Therefore, this assay will be beneficial for those PGD patients SMN exon 7 within multiplex reactions. Therefore, the next step would be to test the accuracy of a test that co-amplifies who are heterozygous for D21S11. Moreover, due to the high heterozygosity of this STR (90%), contaminating DNA can be a single copy gene (i.e. cystic fibrosis transmembrane regulator gene) with SMN. identified, as those profiles are not derived from parental patterns. Only two of 43 (5%) blank controls (for normal and SMA-affected lymphocytes) gave a positive signal after two gene analysis. Our results, as well as those by other groups, Am. J. Hum. Genet., 47, [656] [657] [658] [659] [660] [661] [662] [663] have shown that fluorescent PCR can be used effectively to Findlay, I., Matthews, P., Quirke, P. (1999) Preimplantation genetic diagnosis screen samples for common aneuploidies. By comparing peak using fluorescent polymerase chain reaction: results and future ratios, the gene copy number of an unknown PCR fragment developments. J. Assist. Reprod. Genet., 16, [199] [200] [201] [202] [203] [204] [205] [206] I ., Matthews, P., Toth, T. et al. (1998a) Same day diagnosis of Down's can be determined when an internal single copy control is cosyndrome and sex in single cells using multiplex fluorescent PCR. Mol.
amplified within the reaction. Presently, a rapid genetic test Pathol., 51, [164] [165] [166] [167] does not exist for determining SMA carrier status. Parents Findlay, I., Toth, T., Matthews, P. et al. (1998b) Rapid trisomy diagnosis (21, only discover that they are carriers for the SMA mutation 18, and 13) using fluorescent PCR and short tandem repeats: applications for prenatal diagnosis and preimplantation genetic diagnosis. J. Assist.
after they have had an affected child. In terms of disease Reprod. Genet., 15, [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] management, it would be important to see if a quantitative Findlay, I., Taylor, A., Quirke, P. et al. (1997) In our study, we developed multiplex reactions using DNA
